Search

Simulations Plus Inc

Slēgts

SektorsVeselības aprūpe

18.39

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

18.39

Max

18.41

Galvenie mērījumi

By Trading Economics

Ienākumi

-960K

3.6M

Pārdošana

-2.4M

22M

P/E

Sektora vidējais

46

56.659

EPS

0.3

Peļņas marža

16.335

Darbinieki

212

EBITDA

-6.3M

1.1M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

-6.25% downside

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

963K

372M

Iepriekšējā atvēršanas cena

18.39

Iepriekšējā slēgšanas cena

18.39

Ziņu noskaņojums

By Acuity

50%

50%

143 / 340 Rangs Healthcare

Simulations Plus Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 1. sept. 23:56 UTC

News

Wix.com Ltd faces a securities class action lawsuit over alleged false statements about its AI products, leading shares to trade lower in after-market hours.

2026. g. 1. sept. 23:56 UTC

News

AbbVie Inc. has filed for a new Skyrizi regimen to treat Crohn's disease. Shares are lower in after-market hours amid broader market pressure from rising oil prices.

2026. g. 1. sept. 23:51 UTC

News

Telephone and Data Systems withdraws Array Digital Infrastructure acquisition proposal and resumes share repurchase program. Shares rise in after-market trading.

2026. g. 1. sept. 23:51 UTC

News
Correlated Moves

EOG Resources shares are higher after the company announced participation in the Barclays Energy-Power Conference, with oil prices surpassing $90 per barrel.

2026. g. 1. sept. 23:46 UTC

News
Correlated Moves

Biontech SE's shares are lower in after-market hours following a decline in Moderna and amid ongoing challenges, including a halted cancer trial.

2026. g. 1. sept. 23:46 UTC

News

Hormel Foods Corp will participate in the 2026 Barclays Global Consumer Staples Conference. Shares are trading higher during after-market hours following the announcement.

2026. g. 1. sept. 23:41 UTC

News

StoneX Group Inc shares are lower in after-market hours, reflecting broader market concerns over rising oil prices and ongoing inflation fears amid recent negative trends.

2026. g. 1. sept. 23:41 UTC

News

Carrier Global shares are higher in after-market trading ahead of the Morgan Stanley conference on September 15, 2026, featuring CEO David Gitlin.

2026. g. 1. sept. 23:41 UTC

News
Correlated Moves

ONEOK Inc's shares are higher in after-market trading following several rating adjustments, including price target increases from Scotiabank and Morgan Stanley.

2026. g. 1. sept. 23:41 UTC

News

Dropbox shares fell in after-market hours following a Bloomberg report on a data breach affecting about 5,000 user accounts.

2026. g. 1. sept. 23:36 UTC

News

G-III Apparel Group has acquired the Marc Jacobs brand from LVMH. Shares are trading higher in after-market hours following the announcement.

2026. g. 1. sept. 23:36 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidneyintelX.dkd testing, contributing to a modest rise in shares during after-market hours.

2026. g. 1. sept. 23:31 UTC

News
Social Media

PBF Energy shares advanced in after-market trading following the release of its 2025 Sustainability Data Supplement, amid rising crude oil prices above $90.

2026. g. 1. sept. 23:31 UTC

News
Correlated Moves
Social Media

Hong Kong's Exchange Fund fell to HK$4.404 trillion in July, with CAD/HKD trading lower amid rising crude oil prices and inflation concerns.

2026. g. 1. sept. 23:26 UTC

News

Shareholders approve increase of authorized shares to 135 million.

2026. g. 1. sept. 23:26 UTC

News

Tencent Music Entertainment shares are lower in after-market hours following a proposed public offering of senior unsecured notes for refinancing and share repurchases.

2026. g. 1. sept. 23:21 UTC

News

Enovix Corp's drone battery portfolio is now TAA-compliant, boosting its U.S. defense supply chain position. Shares are lower in after-market trading amid broader market trends.

2026. g. 1. sept. 23:21 UTC

News

Lamar Advertising Co declared a quarterly cash dividend of $1.65 per share, up from $1.60, as shares traded lower in after-market hours.

2026. g. 1. sept. 23:16 UTC

News

BridgeBio Pharma shares are lower in after-market hours following a $500 million mixed securities shelf filing, raising concerns about potential dilution.

2026. g. 1. sept. 23:16 UTC

News

Emerson Electric is trading higher in after-market hours following multiple analyst rating adjustments and price target changes from various firms.

2026. g. 1. sept. 23:16 UTC

News

Adecoagro SA completed the R$705 million acquisition of Caarapó Mill, enhancing operations in Mato Grosso do Sul. Shares are trading higher after the announcement.

2026. g. 1. sept. 23:16 UTC

News

ResMed Inc has initiated a $450 million accelerated share repurchase agreement, contributing to higher shares in after-market trading. Final settlement is set for December 2026.

2026. g. 1. sept. 23:16 UTC

News

SoFi Technologies Inc shares rose in after-market hours following Scotiabank's initiation of coverage with a Sector Outperform rating and a price target of $25.00.

2026. g. 1. sept. 23:16 UTC

News
Social Media

Palantir Technologies' subsidiary secured a prime contract with the Army for eight TITAN ground station systems, boosting shares slightly higher in after-hours trading.

2026. g. 1. sept. 23:16 UTC

News
Correlated Moves
Social Media

CHF/HKD declines amid geopolitical tensions and a decrease in Hong Kong's Exchange Fund assets, which fell to HK$4.404 trillion at July's end.

2026. g. 1. sept. 23:06 UTC

News
Social Media

Snowflake shares are higher in after-market trading as discussions on social media build ahead of its earnings report, with revenue expectations at $1.48 billion.

2026. g. 1. sept. 23:06 UTC

News

Union Pacific shares are lower in after-market trading, amid rising oil prices and inflation concerns, despite updates on its merger with Norfolk Southern.

2026. g. 1. sept. 23:06 UTC

News

Sprouts Farmers Market shares fell in after-hours trading following the announcement of a leadership transition, with Nick Konat set to become CEO in January 2027.

2026. g. 1. sept. 23:06 UTC

News
Correlated Moves
Social Media

The USD/DKK is trading higher as rising oil prices raise inflation concerns amid geopolitical tensions in the Middle East.

2026. g. 1. sept. 23:06 UTC

News
Social Media

Alphabet Inc. shares rose in after-hours trading on positive sentiment surrounding its upcoming AI model, Gemini 3.8 Flash, expected to enhance coding capabilities.

Salīdzinājums

Cenas izmaiņa

Simulations Plus Inc Prognoze

Cenas mērķis

By TipRanks

-6.25% uz leju

Prognoze 12 mēnešiem

Vidējais 17.25 USD  -6.25%

Augstākais 18.5 USD

Zemākais 16 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Simulations Plus Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

4 ratings

0

Pirkt

4

Turēt

0

Pārdot

Noskaņojums

By Acuity

143 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat